Asia
China APproves Jiangsu CoWin Biotech Subsidiary's Respiratory Pathogen Detection Kits
China's drug regulator granted Jiangsu CoWin Biotech (SHA:688426) subsidiary Jiangsu Jianwei Diagnostic Technology a medical device certificate for six of its respiratory pathogen nucleic acid detection kits, according to a Saturday disclosure to the Shanghai bourse.The kits detect six kinds of lower respiratory tract pathogens, including Haemophilus influenzae capsulatum, Klebsiella pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, and Pseudomonas aeruginosa.
SHA:688426
